Related references
Note: Only part of the references are listed.Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
Baisheng Li et al.
NATURE COMMUNICATIONS (2022)
If Young Children's Risk of SARS-CoV-2 Infection Is Similar to That of Adults, Can Children Also Contribute to Household Transmission?
Flor M. Munoz
JAMA PEDIATRICS (2022)
A Comparison of Five SARS-CoV-2 Molecular Assays With Clinical Correlations
Gary W. Procop et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
Satoshi Kutsuna et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2021)
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
S. F. Lumley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Seroconversion and Viral Clearance in Patients Hospitalized With COVID-19: Viral Load Predicts Antibody Response
Mar Masia et al.
OPEN FORUM INFECTIOUS DISEASES (2021)
Humoral signatures of protective and pathological SARS-CoV-2 infection in children
Yannic C. Bartsch et al.
NATURE MEDICINE (2021)
Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children
Melanie R. Neeland et al.
NATURE COMMUNICATIONS (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Delayed production of neutralizing antibodies correlates with fatal COVID-19
Carolina Lucas et al.
NATURE MEDICINE (2021)
Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues
Fan Yang et al.
SCIENCE (2021)
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
Kevin J. Selva et al.
NATURE COMMUNICATIONS (2021)
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies
Nicola Cotugno et al.
CELL REPORTS (2021)
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
Andrew Letizia et al.
LANCET RESPIRATORY MEDICINE (2021)
Natural mucosal barriers and COVID-19 in children
Carl A. Pierce et al.
JCI INSIGHT (2021)
Association of Age With SARS-CoV-2 Antibody Response
He S. Yang et al.
JAMA NETWORK OPEN (2021)
Incidence of SARS-CoV-2 infection in health care workers from Northern Italy based on antibody status: immune protection from secondary infection- A retrospective observational case-controlled study
Francesca Rovida et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
A correlate of protection for SARS-CoV-2 vaccines is urgently needed
Florian Krammer
NATURE MEDICINE (2021)
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers
Francesco Bonfante et al.
PEDIATRICS (2021)
Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection
Serena Marchi et al.
PLOS ONE (2021)
Evidence for antibody as a protective correlate for COVID-19 vaccines
Kristen A. Earle et al.
VACCINE (2021)
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
Carolyn A. Cohen et al.
NATURE COMMUNICATIONS (2021)
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery
Chengqian Feng et al.
NATURE COMMUNICATIONS (2021)
Covid-19: Cases in children rise sharply in US as doctors call for vaccine approval
Janice Hopkins Tanne
BMJ-BRITISH MEDICAL JOURNAL (2021)
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
A Sarah Walker et al.
eLife (2021)
Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan
Shu Yazaki et al.
JAMA ONCOLOGY (2021)
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Carolina Garrido et al.
JCI INSIGHT (2021)
Predictors of Nonseroconversion after SARS-CoV-2 Infection
Weimin Liu et al.
EMERGING INFECTIOUS DISEASES (2021)
Persistence of SARS-CoV-2-Specific IgG in Children 6 Months After Infection, Australia
Zheng Quan Toh et al.
EMERGING INFECTIOUS DISEASES (2021)
Seroprevalence of SARS-CoV-2 antibodies in children: a prospective multicentre cohort study
Thomas Waterfield et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2021)
SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63
Bezawit A. Woldemeskel et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
Frauke Muecksch et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum
Stuart P. Weisberg et al.
NATURE IMMUNOLOGY (2021)
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features
Louise C. Rowntree et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
A serological assay to detect SARS-CoV-2 seroconversion in humans
Fatima Amanat et al.
NATURE MEDICINE (2020)
Coronavirus Infections in Children Including COVID-19 An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children
Petra Zimmermann et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2020)
The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
Rita Carsetti et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis
Fatimah S. Dawood et al.
LANCET INFECTIOUS DISEASES (2020)
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert et al.
NATURE (2020)
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Quan-Xin Long et al.
NATURE MEDICINE (2020)
SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons
Nele Wellinghausen et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Carl A. Pierce et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Antibody response to SARS-CoV-2 infection in humans: A systematic review
Nathan Post et al.
PLOS ONE (2020)
B Cell Subsets as Severity-Associated Signatures in COVID-19 Patients
Victor A. Sosa-Hernandez et al.
FRONTIERS IN IMMUNOLOGY (2020)
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg et al.
SCIENCE (2020)
Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals
Fang Gong et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19
Shidan Tosif et al.
NATURE COMMUNICATIONS (2020)
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
Xiangyu Chen et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
Katherine V. Houser et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza
Anthony DiPiazza et al.
FRONTIERS IN IMMUNOLOGY (2016)